Updated Jul 16, 2026
Warden Charles M has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Charles M. Warden is identified in SEC filings as a director of Ocular Therapeutix, Inc. (OCUL) as of the filing date 2026-06-12. The available context indicates his role on the company’s board of directors, reflecting governance responsibilities within a public biotechnology company. Publicly disclosed information in the provided SEC context does not specify prior roles, education, or career history beyond his board membership.
| Role | Director |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-12 | OCUL | OCULAR THERAPEUTIX, INC | A — Grant or award | 14.0K | $0.00 |
Charles M. Warden is identified in SEC filings as a director of Ocular Therapeutix, Inc. (OCUL) as of the filing date 2026-06-12. The available context indicates his role on the company’s board of directors, reflecting governance responsibilities within a public biotechnology company. Publicly disclosed information in the provided SEC context does not specify prior roles, educa…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Warden Charles M profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.